Icahn School of Medicine at Mount Sinai
New method of sequencing mitochondrial DNA
Our innovation is a method of purifying and sequencing mitochondrial DNA (mtDNA). The objective is to develop mtDNA biomarkers for neurological disorders and drug-resistance in cancer.
For more information about how to join us please contact Executive Director, Mary Howard at Mary@FirstXFounder.com